Cancer management and reimbursement aspects in Germany

an overview demonstrated by the case of colorectal cancer

authored by

J. Matthias Von Der Schulenburg, Anne Prenzler, Willemien Schurer

Abstract

This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.

Organisation(s)

Institute of Insurance Business Administration

External Organisation(s)

London School of Economics and Political Science

Type

Article

Journal

European Journal of Health Economics

Volume

10

Pages

S21-S26

ISSN

1618-7598

Publication date

01.2010

Publication status

Published

Peer reviewed

Yes

ASJC Scopus subject areas

Economics, Econometrics and Finance (miscellaneous), Health Policy

Sustainable Development Goals

SDG 3 - Good Health and Well-being

Electronic version(s)

https://doi.org/10.1007/s10198-009-0194-x (Access: Closed)